Prognostic value and potential function of a novel heme-related LncRNAs signature in gastric cancer

被引:0
|
作者
Ma, Shuo [1 ]
Liao, Wei [2 ]
Chen, Yinhao [3 ]
Gan, Lin [4 ]
机构
[1] Southeast Univ, Sch Med, Nanjing 210009, Jiangsu, Peoples R China
[2] Chongqing Univ, Fuling Hosp, Dept Surg & Anesthesia, Chongqing 408000, Peoples R China
[3] Univ Hosp Bonn, Ctr Integrated Oncol CIO, Dept Integrated Oncol, D-53127 Bonn, Germany
[4] Chongqing Univ, Fuling Hosp, Dept Gen Surg, Chongqing 408000, Peoples R China
关键词
Gastric cancer; Long non-coding RNA; Heme metabolism; Immune infiltration; Immunotherapy; COLON-CANCER; HYPERPROLIFERATION; CYTOTOXICITY; ANGIOGENESIS; ACCUMULATION; INHIBITORS; CELLS; MEAT;
D O I
10.1016/j.cellsig.2024.111152
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Heme is a coordination complex formed by the binding of iron ions and porphyrin rings. Its metabolic processes are associated with various cancers, including gastric cancer (GC). In recent years, long non-coding RNAs (LncRNAs) have been identified as key regulatory factors in GC. However, the role of LncRNAs associated with heme metabolism in GC and their relationship with prognosis have not been reported. In this study, we constructed a novel LncRNAs signature related to heme metabolism (HMlncSig) and validated its prognostic value for predicting the survival of GC patients through training, test, and entire cohorts. Kaplan-Meier analysis demonstrated that patients in the high-risk group had shorter survival times. Univariate and multivariate Cox regression analysis showed that HMlncSig was an independent prognostic indicator for GC patients, regardless of other clinical pathological features. Gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis and gene set variation analysis pathways showed that the activation of these markers may be involved in tumor progression, influencing the survival of GC patients. The nomogram, based on HMlncSig score and clinical features, demonstrated the strong predictive ability of this signature. Additionally, significant differences were observed between the high-risk and low-risk groups in terms of immune cell subtypes, expression of immune checkpoint genes, and response to chemotherapy and immunotherapy. Through clinical validation, we found that the risk score and heme levels of GC patients were both significantly elevated and correlated with the degree of malignancy. Furthermore, we found that AP000692.1, a key gene in this signature, promoted the proliferation, migration, and invasion of GC cells. In conclusion, our HMlncSig model has significant predictive value for the prognosis of GC patients and can provide clinical guidance for personalized immunotherapy.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] CeNETs analysis reveals the prognostic value of a signature integration from five lncRNAs in breast cancer
    Wang, Ke
    Liao, Caihua
    Zhong, Qiong
    Dong, Haiyan
    Zhang, Tiancheng
    Jin, Rongzhong
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (08) : 13509 - 13519
  • [42] Prognostic Value of a lncRNA Signature in Gastric Cancer: A lncRNA Expression Analysis
    Ni, Shujuan
    Xu, Midie
    Tan, Cong
    Huang, Dan
    Weng, Weiwei
    Zhang, Qiongyan
    Sheng, Weiqi
    Du, Xiang
    MODERN PATHOLOGY, 2016, 29 : 189A - 189A
  • [43] Prognostic Value of a lncRNA Signature in Gastric Cancer: A lncRNA Expression Analysis
    Ni, Shujuan
    Xu, Midie
    Tan, Cong
    Huang, Dan
    Weng, Weiwei
    Zhang, Qiongyan
    Sheng, Weiqi
    Du, Xiang
    LABORATORY INVESTIGATION, 2016, 96 : 189A - 189A
  • [44] Prognostic value and immune landscapes of disulfidptosis-related lncRNAs in bladder cancer
    Liu, Yijiang
    Tao, Huijing
    Jia, Shengjun
    Wang, Haozheng
    Guo, Long
    Hu, Zhuozheng
    Zhang, Wenxiong
    Liu, Fei
    MOLECULAR AND CLINICAL ONCOLOGY, 2025, 22 (02)
  • [45] Expression status and prognostic value of autophagy-related lncRNAs in prostate cancer
    Chen, Guo
    Qin, Xiaoping
    Wang, Yu
    Gao, Biyun
    Ling, Muan
    Yin, Wenjun
    Li, Yutong
    Pan, Bin
    CELL CYCLE, 2022, 21 (16) : 1684 - 1696
  • [46] Identification of a novel nine-SnoRNA signature with potential prognostic and therapeutic value in ovarian cancer
    Zhu, Wenjing
    Zhang, Tao
    Luan, Shaohong
    Kong, Qingnuan
    Hu, Wenmin
    Zou, Xin
    Zheng, Feibo
    Han, Wei
    CANCER MEDICINE, 2022, 11 (10): : 2159 - 2170
  • [47] Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer
    Qu, Xinyu
    Shi, Zhiwen
    Guo, Jingjing
    Guo, Chenyan
    Qiu, Junjun
    Hua, Keqin
    CANCER MEDICINE, 2021, 10 (19): : 6881 - 6896
  • [48] In silico identification of novel lncRNAs with a potential role in diagnosis of gastric cancer
    Delshad, Encieh
    Shamsabadi, Fatemeh T.
    Bahramian, Shabbou
    Mehravar, Fatemeh
    Maghsoudi, Hossein
    Shafiee, Mohammad
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (07): : 1954 - 1962
  • [49] Prognostic and predictive value of a novel immune-related gene pair signature in prostate cancer
    Wang, Jinbao
    Zhou, Xianghong
    Qiu, Shi
    Wei, Qiang
    ASIAN JOURNAL OF SURGERY, 2023, 46 (03) : 1284 - 1285
  • [50] A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
    Zhou, Zheng
    Zhou, Yusong
    Liu, Wei
    Dai, Jing
    FRONTIERS IN GENETICS, 2023, 14